Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
Karly C. Sourris(Baker Heart and Diabetes Institute), Barbora de Courten(Monash Health), Maximilian de Courten(Victoria University), Markus P. Schlaich(The University of Western Australia), Bronwyn A. Kingwell(CSL (Australia)), Vibhasha Chand(Baker Heart and Diabetes Institute), Sonia Dougherty(Baker Heart and Diabetes Institute), Jasmine G. Lyons(Baker Heart and Diabetes Institute), Nora E. Straznicky(Baker Heart and Diabetes Institute), Josephine M. Forbes(Translational Research Institute), M. E. Cooper(The University of Melbourne), Mariee T. Grima(Baker Heart and Diabetes Institute)
Cited by 23
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
|New England Journal of Medicine|2009|774